Weazel perhaps we should list on the nasdaq as 007 catalyst has stated a number of times that we are a US based company. Sight are many times our present valuation despite that they have significant debt and are not profitable. We have no debt and are nearly profitable and we have the 2RT elephant in the room. I know listing is a difficult and expensive process but if the 2RT business comes to fruition our pricing on nasdaq could be many times what it would be on the asx so I would list there .
Nova Eye Medical (EYE) Discussion, page-2087
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.025(11.6%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 25.0¢ | 22.0¢ | $250.2K | 1.070M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30000 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 3900 | 1 |
View Market Depth
| Last trade - 15.59pm 04/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |